Đang chuẩn bị liên kết để tải về tài liệu:
Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: A case report

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of surfactant proteins within the alveolar spaces. Autoimmune PAP (APAP) caused by elevated levels of GM-CSF autoantibodies (GM-Ab) is very rarely associated with systemic autoimmune disease. Here we report a case of APAP manifested during immunosuppressive treatment for polymyositis with interstitial lung disease. |

TÀI LIỆU LIÊN QUAN

Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis

Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features

Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis

Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: A case report

Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features

Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: A retrospective cohort study

Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema

N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: A retrospective cohort study

Pulmonary granulomas in a patient with positive ANCA and history of tuberculosis: Case report